In November, researchers from the Faculty of Pharmaceutics of Voronezh State University visited the production facility (in Neumarkt, Germany) and the research facility (in Innsbruck, Austria) of Bionorica SE pharmaceutical company – a world leader among manufacturers of herbal medicines. The visit was a part of the partnership agreement between our university and the company.
Our delegation included the dean of the Faculty of Pharmaceutics, Alexey Slivkin, Associate professor of the Department of Pharmaceutical Chemistry and Pharmaceutical Engineering, Olga Trineeva, and Associate professors of the Department of Economics and Management in Pharmaceutics and Pharmacognosy, Alevtina Gudkova and Maria Kurolap.
In the head office of the company in Neumarkt, the delegation was welcomed by the chair of the board and Honorary Doctor of VSU, professor Michael Popp. He told the guests about phytoneering. The heads of the company’s departments also told our researchers about the production process, as well as the cutting-edge research and innovative technologies the company applies to manufacture new effective medicines, the quality control methods, the non-clinical and clinical studies, and the legal procedures of registering new medicines in Europe.
Our researchers also visited the production facility of the company in Neumarkt, where they saw the equipment and watched the production cycles that will be introduced at the pharmaceutical plant of Bionorica SE in the Maslovsky industrial park, the construction of which began in July 2017.
Then our delegation visited the University of Innsbruck (Austria) where they met professor Günther K. Bonn, Director of the Institute of Analytical Chemistry and Radiochemistry of the University of Innsbruck, member of the Nobel Committee on Chemistry, Council of the Government of Austria on Science, and research supervisor of professor Michael Popp. He told the guests about the Phyto-Valley, a research facility in Tyrol - a picturesque place in the Alps along the river Inn.
They then visited research laboratories of the University of Innsbruck, the Chemistry and Biomedicine Centre, the Austrian Drug Screening Institute ADSI, and the Bionorica Research centre.
Our researchers studied the way specialists are trained for the company and how the industry is organised. They also discussed the possibility of carrying our joint research projects and launching academic exchange programmes for students and postgraduates, as well as opening a joint master’s degree programme “Industrial Pharmacy”, which will be enhanced by practical courses presented by Bionorica SE specialists. Professors from the University of Innsbruck will also come to VSU to give lectures to the students of the Faculty of Pharmaceutics.